Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EV71 Vaccine Combined with HBV and MenA Vaccines
NCT06209398Phase 4Active, not recruiting
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- May 2018
- Primary completion
- Dec 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of enterovirus 71 vaccine (vero cell), inactivated in HIV-associated central nervous system involvement (HAND), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started May 2018; status: active, not recruiting.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
03
Conditions
HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT06209398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06209398.